首页> 中文期刊> 《世界核心医学期刊文摘:妇产科学分册》 >一种使用半巢式PCR及逆转录杂交法检测人类高危乳头瘤病毒并进行基因分型的简便方法

一种使用半巢式PCR及逆转录杂交法检测人类高危乳头瘤病毒并进行基因分型的简便方法

         

摘要

To develop a simple and cost-effective method for the detection and genotypin g of high-risk human papillomaviruses (HPV)-using seminested polymerase chain reaction (PCR) and reverse hybridization. Cervical swabs for HPV testing were co llected from 127 women with normal cervical cytology and 57 patients with cervic al lesions of various degrees. After DNA isolation, PCR amplification was first carried out using MY11 and MY09/HMB01 primers, then labeled by seminested PCR us ing the first PCR products and MY 11/bioGP6+primers. One fifth of the second PC R products were resolved by gel electrophoresis. Genotyping for high-risk HPV w as done separately, using the remaining products, by a high-risk HPV chip, whic h contained 13 type-specific oligonucleotides on a nylon membrane. The final re sult was detected by colorimetric change on the chip under direct visualization. High-risk HPV DNA was detected in 19 (15%) of 127 women with normal cervical smear cytology, in 26 (89.7%) of 29 patients with cervical intraepithelial neop lasia (CIN), and in 27 (96.4%) of 28 patients with invasive cervical carcinoma. Multiple high-risk HPV infections were detected in five cases. HPV type 16 was the most frequent type of infection, comprising 34.5%and 53.6%of the patients with CIN and invasive carcinoma, respectively. The samples without a visible 19 0-bp band on electrophoresis exclusively showed negative hybridization results. This method could detect one to two copies of the HPV-16 genome derived from o ne SiHa cell. The overall sensitivity of HPV detection was 25 to 50 copies of HP V genome for each specimen. Thirteen high-risk types and twenty-four different types of HPV DNA showed specific hybridization without any cross-reaction. Our results demonstrated the feasibility and optimistic prospects for this simple a nd cheap method of high-risk HPV genotyping. This technology can be easily set up in a routine molecular laboratory and would probably be of great value in cer vical cancer prevention programs.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号